POMZP3

gene
On this page

Also known as POM-ZP3POM121

Summary

POMZP3 (POM121 and ZP3 fusion, HGNC:9203) is a protein-coding gene on chromosome 7q11.23, encoding POM121 and ZP3 fusion protein (Q6PJE2).

This gene appears to have resulted from a fusion of DNA sequences derived from 2 distinct loci, specifically through the duplication of two internal exons from the POM121 gene and four 3’ exons from the ZP3 gene. The 5’ end of this gene is similar to the 5` coding region of the POM121 gene which encodes an integral nuclear pore membrane protein. However, the protein encoded by this gene lacks the nuclear pore localization motif. The 3’ end of this gene is similar to the last 4 exons of the zona pellucida glycoprotein 3 (ZP3) gene and the encoded protein retains one zona pellucida domain. Multiple protein isoforms are encoded by transcript variants of this gene.

Source: NCBI Gene 22932 — RefSeq curated summary.

At a glance

  • MANE Select transcript: NM_012230

Identifiers

Gene identifiers

FieldValue
HGNC IDHGNC:9203
Approved symbolPOMZP3
NamePOM121 and ZP3 fusion
Location7q11.23
Locus typegene with protein product
StatusApproved
AliasesPOM-ZP3, POM121
Ensembl geneENSG00000146707
Ensembl biotypeprotein_coding
OMIM600587
Entrez22932

Gene structure

Transcript identifiers

Ensembl transcripts: 11 — 10 protein_coding, 1 nonsense_mediated_decay

ENST00000275569, ENST00000310842, ENST00000424818, ENST00000441393, ENST00000454397, ENST00000879744, ENST00000879745, ENST00000879746, ENST00000879747, ENST00000936948, ENST00000960016

RefSeq mRNA: 2 — MANE Select: NM_012230 NM_012230, NM_152992

CCDS: CCDS43606, CCDS5590

Canonical transcript exons

ENST00000310842 — 7 exons

ExonStartEnd
ENSE000018156557662670876627279
ENSE000024524717662600076626215
ENSE000024759227662552276625683
ENSE000034668457660998676610215
ENSE000035376287661818376618300
ENSE000035526047661145476611591
ENSE000037910557661172276611813

Expression profiles

Bgee: expression breadth ubiquitous, 141 present calls, max score 89.78.

Top tissues by expression

141 total, by Bgee expression score (0-100, higher = more expressed):

TissueAnatomy IDExpression scoreQuality
left testisUBERON:000453389.78gold quality
right testisUBERON:000453488.85gold quality
testisUBERON:000047388.81gold quality
lower esophagus mucosaUBERON:003583488.41gold quality
apex of heartUBERON:000209888.36gold quality
skeletal muscle tissueUBERON:000113487.00gold quality
cortical plateUBERON:000534386.97gold quality
mucosa of stomachUBERON:000119986.80gold quality
right coronary arteryUBERON:000162586.60gold quality
lower esophagus muscularis layerUBERON:003583386.42gold quality
lower esophagusUBERON:001347386.40gold quality
embryoUBERON:000092286.02gold quality
ganglionic eminenceUBERON:000402386.02gold quality
gastrocnemiusUBERON:000138885.99gold quality
esophagogastric junction muscularis propriaUBERON:003584185.96gold quality
skeletal muscle organUBERON:001489285.81gold quality
muscle of legUBERON:000138385.77gold quality
popliteal arteryUBERON:000225085.75gold quality
tibial arteryUBERON:000761085.75gold quality
muscle layer of sigmoid colonUBERON:003580585.73gold quality
right ovaryUBERON:000211885.58gold quality
muscle tissueUBERON:000238585.57gold quality
primordial germ cell in gonadCL:0000670 ∩ UBERON:000099185.50gold quality
left ovaryUBERON:000211985.36gold quality
ascending aortaUBERON:000149685.25gold quality
thoracic aortaUBERON:000151585.08gold quality
cerebellumUBERON:000203785.00gold quality
ovaryUBERON:000099284.99gold quality
hindlimb stylopod muscleUBERON:000425284.99gold quality
cerebellar cortexUBERON:000212984.91gold quality

Single-cell (SCXA)

Detected in 2 experiment(s), a significant marker in 1.

ExperimentMarker?Max mean expression
E-ANND-3yes2.80
E-MTAB-6142no61.19

Regulation

Is transcription factor: no

miRNA regulators (miRDB)

6 targeting POMZP3, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):

miRNAMax scoreAvg scoremiRNA target_count
HSA-MIR-4659A-3P99.8072.624248
HSA-MIR-4659B-3P99.8072.624248
HSA-MIR-589-5P98.7266.96927
HSA-MIR-138-1-3P98.2567.89867
HSA-MIR-6773-3P98.1765.511213
HSA-MIR-6748-3P97.2065.66836

Cross-species orthologs

9 orthologs

OrganismSymbolGene ID
danio_reriozp3eENSDARG00000016908
danio_reriozp3bENSDARG00000039828
danio_reriozp3a.1ENSDARG00000042129
danio_reriozp3a.2ENSDARG00000042130
danio_reriozp3.2ENSDARG00000090768
danio_reriozp3ENSDARG00000114958
danio_reriozp3.2ENSDARG00000115457
mus_musculusZp3ENSMUSG00000004948
rattus_norvegicusZp3ENSRNOG00000001434

Paralogs (1): ZP3 (ENSG00000188372)

Protein

Protein identifiers

POM121 and ZP3 fusion proteinQ6PJE2 (reviewed: Q6PJE2)

All UniProt accessions (4): Q6PJE2, C9J370, C9JER0, H7C4D5

UniProt curated annotations — full annotation on UniProt →

Tissue specificity. Expressed in spleen, thymus, pancreas, testis, ovary, small intestine, colon and lymphocytes.

Isoforms (2)

UniProt IDNamesCanonical?
Q6PJE2-41yes
Q6PJE2-52

RefSeq proteins (2): NP_036362, NP_694537 (=MANE)

Domains & families (InterPro)

IDNameType
IPR042235ZP-C_domHomologous_superfamily
IPR055355ZP-CDomain

Pfam: PF00100

UniProt features (5 total): chain 1, region of interest 1, compositionally biased region 1, splice variant 1, sequence variant 1

Structure

Experimental structures (PDB)

0 structures.

Predicted structure (AlphaFold)

ModelpLDDTFraction very-high
AF-Q6PJE2-F173.490.39

Function

Pathways and Gene Ontology

Reactome pathways

0 pathways

MSigDB gene sets: 321 (showing top): MORF_DNMT1, REACTOME_INTERACTIONS_OF_VPR_WITH_HOST_CELLULAR_PROTEINS, GOBP_INTRACELLULAR_PROTEIN_TRANSPORT, REACTOME_CYTOKINE_SIGNALING_IN_IMMUNE_SYSTEM, TGCTGCT_MIR15A_MIR16_MIR15B_MIR195_MIR424_MIR497, GCANCTGNY_MYOD_Q6, REACTOME_VIRAL_MESSENGER_RNA_SYNTHESIS, GRAESSMANN_APOPTOSIS_BY_DOXORUBICIN_UP, MORF_RRM1, GRAESSMANN_RESPONSE_TO_MC_AND_DOXORUBICIN_UP, MORF_UBE2N, GENTILE_RESPONSE_CLUSTER_D3, MORF_HDAC2, RIZKI_TUMOR_INVASIVENESS_3D_DN, GOBP_ESTABLISHMENT_OF_PROTEIN_LOCALIZATION_TO_ORGANELLE

GO Biological Process (0):

GO Molecular Function (0):

GO Cellular Component (2): nucleoplasm (GO:0005654), nuclear membrane (GO:0031965)

GO top-level categories

Rollup of top GO terms by namespace:

CategoryTerms
nuclear lumen1
cellular anatomical structure1
nucleus1
nuclear envelope1
organelle membrane1

Protein interactions and networks

STRING

280 interactions, top by confidence (×1000):

Protein AProtein BPartner UniProtScore
POMZP3OR4L1Q8NH43507
POMZP3FRG2BQ96QU4474
POMZP3ZP1P60852445
POMZP3DNAAF8Q8IYS4431
POMZP3ZP4Q12836404
POMZP3ZP2Q05996387
POMZP3OR5A2Q8NGI9379
POMZP3ZNF708P17019375
POMZP3ZAR1Q86SH2375
POMZP3FAM171BQ6P995372
POMZP3CLEC2LP0C7M8370
POMZP3HRCT1Q6UXD1370
POMZP3HSD17B12Q53GQ0352
POMZP3FBRSL1Q9HCM7350
POMZP3C4BPBP20851349

IntAct

6 interactions, top by confidence:

ABTypeScore
POMZP3ADORA2Apsi-mi:“MI:0915”(physical association)0.370
POMZP3NMIpsi-mi:“MI:0915”(physical association)0.370
KPNA2POM121Cpsi-mi:“MI:0914”(association)0.350
POMZP3PRRC2Apsi-mi:“MI:0914”(association)0.350
SLC25A25HAX1psi-mi:“MI:0914”(association)0.350

BioGRID (11): POMZP3 (Two-hybrid), NMI (Two-hybrid), POMZP3 (Proximity Label-MS), POMZP3 (Two-hybrid), ATXN3 (Affinity Capture-MS), PRRC2A (Affinity Capture-MS), POMZP3 (Affinity Capture-MS), POMZP3 (Affinity Capture-MS), POMZP3 (Affinity Capture-RNA), APP (Reconstituted Complex), POMZP3 (Two-hybrid)

ESM2 similar proteins: A0A0D9SF12, A0A1Z2R986, A2AWH2, A6QNY1, C3VD30, D3ZF92, E7F5F0, E7FKV8, M3WHG5, O55034, O70303, O75509, O76081, O88393, O94966, P26342, P35054, P35125, P49763, P79209, P97946, Q03167, Q0VFL4, Q3T191, Q3UPF5, Q4TUC0, Q503Y8, Q5EB20, Q5M889, Q5XI33, Q62005, Q6B9Z1, Q6PJE2, Q6UWQ7, Q6UWV7, Q7TP54, Q7Z2W4, Q810F8, Q91V27, Q91ZV2

Diamond homologs: A6NF01, A6NNC1, A8CG34, P52591, Q3SYA9, Q6PJE2, Q8K3Z9, Q96HA1, Q96KW2, P10761, P21754, P23491, P42098, P48830, P48831, P48832, P48833, P53785, P53786, P79762, P97708, G5E8D7, Q60997, Q8CIZ5, Q95218, Q8N7R1, Q5SW25

SIGNOR signaling

0 interactions.

Disease & clinical

Clinical variants and AI predictions

ClinVar

0 variants total. Per-class counts are floors (≥ shown; pagination cap):

ClassificationCount (floor)
Pathogenic0
Likely pathogenic0
Uncertain significance0
Likely benign0
Benign0

Top pathogenic / likely-pathogenic (0)

SpliceAI

847 predictions. Top by Δscore:

VariantEffectΔscore
7:76610213:TCA:Tacceptor_gain1.0000
7:76610214:CA:Cacceptor_gain1.0000
7:76610214:CACTG:Cacceptor_gain1.0000
7:76610216:C:CCacceptor_gain1.0000
7:76611587:ACCAG:Aacceptor_gain1.0000
7:76611588:CCAG:Cacceptor_gain1.0000
7:76611588:CCAGC:Cacceptor_gain1.0000
7:76611589:CAG:Cacceptor_gain1.0000
7:76611589:CAGC:Cacceptor_gain1.0000
7:76611590:A:Tacceptor_gain1.0000
7:76611592:C:CCacceptor_gain1.0000
7:76611717:CTCA:Cdonor_loss1.0000
7:76611718:TCA:Tdonor_loss1.0000
7:76611719:CAC:Cdonor_loss1.0000
7:76611720:ACC:Adonor_loss1.0000
7:76611721:C:Tdonor_loss1.0000
7:76611811:TAT:Tacceptor_gain1.0000
7:76611813:TCTGC:Tacceptor_loss1.0000
7:76611814:C:CCacceptor_gain1.0000
7:76611814:CT:Cacceptor_loss1.0000
7:76611815:T:Aacceptor_loss1.0000
7:76618177:TCTTA:Tdonor_loss1.0000
7:76618178:CTTAC:Cdonor_loss1.0000
7:76618179:TTA:Tdonor_loss1.0000
7:76618180:TA:Tdonor_loss1.0000
7:76618298:CAG:Cacceptor_gain1.0000
7:76618298:CAGCT:Cacceptor_gain1.0000
7:76618301:C:CCacceptor_gain1.0000
7:76618302:T:Cacceptor_gain1.0000
7:76618302:T:TCacceptor_gain1.0000

AlphaMissense

1236 scored. Top likely-pathogenic:

VariantProtein changeam_pathogenicity
7:76611739:G:CF140L0.971
7:76611739:G:TF140L0.971
7:76611741:A:GF140L0.971
7:76611751:C:AK136N0.971
7:76611751:C:GK136N0.971
7:76618261:G:CF89L0.970
7:76618261:G:TF89L0.970
7:76618263:A:GF89L0.970
7:76618210:G:CF106L0.969
7:76618210:G:TF106L0.969
7:76618212:A:GF106L0.969
7:76618204:A:CF108L0.962
7:76618204:A:TF108L0.962
7:76618206:A:GF108L0.962
7:76618226:A:GF101S0.961
7:76611588:C:AW147C0.946
7:76611588:C:GW147C0.946
7:76618225:G:CF101L0.946
7:76618225:G:TF101L0.946
7:76618227:A:GF101L0.946
7:76618205:A:CF108C0.928
7:76618262:A:CF89C0.926
7:76611590:A:GW147R0.924
7:76611590:A:TW147R0.924
7:76611794:A:GL122P0.921
7:76611744:A:GS139P0.918
7:76611746:C:GC138S0.917
7:76611747:A:TC138S0.917
7:76618226:A:CF101C0.904
7:76611801:A:GC120R0.900

dbSNP variants (sampled 300 via entrez): RS1000170647 (7:76623101 G>C), RS1000431024 (7:76627404 G>T), RS1000484378 (7:76613439 G>A), RS1001087092 (7:76618698 T>C), RS1001181895 (7:76624124 G>A), RS1001212920 (7:76623830 A>C,G), RS1001601998 (7:76618555 AG>A,AGG), RS1002201698 (7:76619328 CA>C), RS1002244778 (7:76624761 A>G), RS1002990483 (7:76610818 C>G,T), RS1003094735 (7:76621155 G>A,T), RS1003295990 (7:76625769 C>A,G,T), RS1003432590 (7:76610523 A>G), RS1003675661 (7:76626055 T>C), RS1004036691 (7:76611889 A>C,G)

Disease associations

OMIM: gene MIM:600587 | disease phenotypes:

GenCC curated gene-disease

Mondo (0):

Orphanet (0):

HPO phenotypes

0 total (0 of 0 shown, HPO-id order):

GWAS associations

0 associations (top):

Drugs & pharmacology

Drug and pharmacology data

Is drug target: no

PharmGKB: 1 entry (VIP=true, CPIC=false)

CTD chemical–gene interactions

24 total (human), top 24 by PubMed support.

ChemicalActions (top 5)PubMed papers
aristolochic acid Iincreases expression1
bisphenol Aincreases expression1
cobaltous chloridedecreases expression1
CGP 52608affects binding, increases reaction1
JP8 aviation fueldecreases expression1
abrineincreases expression1
4-(4-((5-(4,5-dimethyl-2-nitrophenyl)-2-furanyl)methylene)-4,5-dihydro-3-methyl-5-oxo-1H-pyrazol-1-yl)benzoic aciddecreases expression1
Sunitinibdecreases expression1
Benzo(a)pyreneincreases expression1
Doxorubicindecreases expression1
Endosulfanincreases expression1
Ethyl Methanesulfonateincreases expression1
Etoposideaffects response to substance1
Formaldehydeincreases expression1
Methyl Methanesulfonateincreases expression1
Mitoxantroneaffects response to substance1
Smokedecreases expression1
Tobacco Smoke Pollutionincreases expression1
Valproic Acidincreases expression1
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxideincreases expression1
Paclitaxelaffects response to substance1
Copper Sulfateincreases expression1
Lactic Acidincreases expression1
Particulate Matterdecreases expression1

Clinical trials (associated diseases)

0 trials via MONDO — disease-level, not drug-specific.

No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.